Established in 2012, Earum Pharmaceuticals Limited operates within the pharmaceutical sector, specializing in the marketing, trading, and distribution of pharmaceutical formulation products.
Earum Pharmaceuticals offers a comprehensive product range that encompasses diverse categories, including anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/antipyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections.
The company has successfully established its presence in several Indian states, notably Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan, Madhya Pradesh, Manipur, Assam, Meghalaya, Kerala, Telangana, and much more. Furthermore, Earum Pharmaceuticals intends to grow its presence in foreign markets, leveraging its experience and capabilities beyond local borders..
Earum Pharmaceuticals Ltd Stock Quote #
- Open: ₹1.18
- High – Low: ₹1.19 – ₹1.11
- Previous Close: ₹1.16
- Total Traded Value: 46,47,909
- 52 Weeks High: ₹3.21 (Dec 27, 2022)
- 52 Weeks Low: ₹1.10 (Aug 10, 2023)
- Updated On: Aug 11, 2023 4:00 PM
Earum Pharmaceuticals Rights Issue 2023 Detail #
| Issue Open | May 2, 2023 – May 31, 2023 |
| Security Name | Earum Pharmaceuticals Limited |
| Issue Size (Shares) | 246,716,400 |
| Issue Size (Amount) | ₹49.34 Crores |
| Issue Price | ₹2 per share |
| Face Value | ₹2 per share |
| Listing At | BSE |
| Terms of Payment | Investors must pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of the first call, Rs. 0.50 at the time of the second call, and Rs. 0.50 at the time of the third and final call. |
| Entitlement | 4 Equity Shares for every 1 Equity Shares held on the Record Date |
Earum Pharmaceuticals Rights Issue 2023 Issue Timetable #
| Last Date to buy shares | Apr 6, 2023 |
| Record Date | Apr 10, 2023 |
| Credit of Rights Entitlements | Apr 26, 2023 |
| Bid/Offer Opens On | May 2, 2023 |
| Renunciation of Rights Entitlements | May 26, 2023 |
| Bid/Offer Closes On | May 31, 2023 |
| Deemed Date of Allotment | Jun 20, 2023 |
| Credit Date | Jun 21, 2023 |
| Listing Date | Jun 26, 2023 |
Company Financials #
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
|---|---|---|---|---|
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
| Amount in ₹ Crore | ||||
Objects of the Issue: #
The company aims to use the net revenues of the offering to fund the following projects:
- For working capital requirements.
- Repayment of loan.
- General corporate purposes.
Earum Pharmaceuticals Rights Issue 2023 Documents #
Company Contact Information #
A-1106, Empire Business Hub,
Near AUDA Water Tank, Science City Road,
Sola, Ahmedabad – 380060Phone: (079)-48402525
Email: cs@earumpharma.com
Website: http://www.earumpharma.com
Earum Pharmaceuticals Rights Issue 2023 Registrar #
- Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
